ARTICLE https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p1.xml Beaten at the Alamo by the Europeans 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p4.xml Ovarian Cancer Guidelines: Treatment Progress and Controversies 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p7.xml Lessons From ASH 2010: A Focus on NHL 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p13.xml Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p30.xml Myelodysplastic Syndromes 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p57.xml Epidemiology, Natural History, and Practice Patterns of Patients with Myelodysplastic Syndromes in 2010 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p65.xml The Role of Iron Chelation Therapy for Patients With Myelodysplastic Syndromes 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p82.xml Epithelial Ovarian Cancer 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p115.xml Point: Chemosensitivity Assays Have a Role in the Management of Recurrent Ovarian Cancer 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p121.xml Counterpoint: Chemosensitivity Assays for Recurrent Ovarian Cancer 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-p126.xml Indications for Minimally Invasive Surgery for Ovarian Cancer 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-pxxiv.xml Erratum 2019-01-02 https://harbor-dev.pubfactory.com/view/journals/jnccn/9/1/article-pxxvi.xml Oncology Research Program 2019-01-02